Cargando…

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia

The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krajner, Fanni, Hadaya, Laila, McQueen, Grant, Sendt, Kyra-Verena, Gillespie, Amy, Avila, Alessia, Lally, John, Hedges, Emily P., Diederen, Kelly, Howes, Oliver D., Barker, Gareth J., Lythgoe, David J., Kempton, Matthew J., McGuire, Philip, MacCabe, James H., Egerton, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891256/ https://www.ncbi.nlm.nih.gov/pubmed/35236831 http://dx.doi.org/10.1038/s41537-022-00230-2

Ejemplares similares

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

O3.7. EFFECT OF N-ACETYLCYSTEINE ON BRAIN GLUTAMATE LEVELS AND RESTING PERFUSION IN SCHIZOPHRENIA
por: McQueen, Grant, et al.
Publicado: (2018)

Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2018)

Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2019)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
por: Blackman, Graham, et al.
Publicado: (2021)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal (1)H-MRS Studies
por: Egerton, Alice, et al.
Publicado: (2017)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
por: Verbelen, M, et al.
Publicado: (2015)

41.3 COULD CLOZAPINE REDUCE VIOLENT OFFENDING?
por: Bhavsar, Vishal, et al.
Publicado: (2018)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2022)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
por: Gillespie, Amy L., et al.
Publicado: (2017)

Clozapine treatment and risk of severe COVID‐19 infection
por: Ohlis, Anna, et al.
Publicado: (2021)

Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study
por: Cho, J., et al.
Publicado: (2018)

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
por: Kempton, Matthew J., et al.
Publicado: (2015)

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
por: Egerton, Alice, et al.
Publicado: (2022)

Clozapine treatment and risk of COVID-19 infection: retrospective cohort study
por: Govind, Risha, et al.
Publicado: (2021)

A systematic review and meta‐analysis of mental health service use in people who report psychotic experiences
por: Bhavsar, Vishal, et al.
Publicado: (2017)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit
por: Barnes, Thomas RE, et al.
Publicado: (2022)

Using a fingerstick test for haematological monitoring in patients treated with clozapine
por: Atkins, Matthew, et al.
Publicado: (2021)

Impaired verbal memory function is related to anterior cingulate glutamate levels in schizophrenia: findings from the STRATA study
por: Griffiths, Kira, et al.
Publicado: (2022)

Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
por: Millgate, Edward, et al.
Publicado: (2022)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy
por: Segev, Aviv, et al.
Publicado: (2021)

Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
por: Legge, Sophie E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pkvos46l8d39g75h336t1msgcl